EUVIMEDEUVIMED entdecken
Metaanalyse

Meta-Analysis of Adverse Reactions of Botulinum Toxin A in Facial Rejuvenation Treatment

Weiqiang Zhang, Yuqing Wen, Yi Zhong, Qingxia Chen

Aesthetic Plastic Surgery · 2025

DOI: 10.1007/s00266-024-04539-4 ↗

Kurz gefasst

Metaanalyse in der Zeitschrift Aesthetic Plastic Surgery, 2025. Verfasst von Weiqiang Zhang und 3 weiteren Autor:innen. Beteiligte Einrichtung: Burn, Plastic and Wound Repair Surgery, Longyan First Affiliated Hospital of Fujian Medical University, No.105, Jiuyi North Road, Zhongcheng Street, …. Hauptthemen laut MEDLINE: Botulinum Toxins, Type A, Rejuvenation, Skin Aging, Neuromuscular Agents. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 34 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: Facial rejuvenation is a popular non-surgical treatment, and its treatment safety is of key significance to patients. The purpose of this meta-analysis is to compare the effects of botulinum toxin A and placebo on the occurrence of adverse reactions in facial rejuvenation treatment. OBJECTIVE: According to PRISMA guidelines, a comprehensive search was conducted in Chinese and English databases, and 20 randomized controlled trials (RCTs) were included. The main result is to evaluate the level of adverse events (AEs), and the secondary result is to evaluate the level of AEs in crow's feet (CFL), glabellar lines (GL), and forehead lines (FHL). METHODS: The randomized, double-blind, placebo-controlled clinical trial of botulinum toxin A for facial rejuvenation published up to August 2023 was searched by computer, and the completed data were retrieved manually. Two researchers screened out the included studies and evaluated the quality of the literature, and analyzed the included studies with Revman 5.3 software. RESULTS: The 20 RCTs literatures included 7275 cases in the experimental group and 2552 cases in the control group. The AEs level in the experimental group was significantly higher than that in the placebo group (RR=1.22; 95%CI 1.13-1.32; p < 0.00001), and the level of heterogeneity is low (P = 0.11, I2 = 29%). The AE level of patients in CFL test group was significantly higher than that in control group (RR = 1.13; 95%CI 1.02-1.04; P = 0.01), and the level of heterogeneity is low (P = 0.14, I2 = 38%). The level of AE in GL experimental group was significantly higher than that in control group (RR = 1.42; 95%CI 1.21-1.67; p < 0.0001), and the level of heterogeneity is low (P = 0.60, I2 = 0%). The AE level of patients in FHL experimental group was significantly higher than that in control group (RR = 1.53; 95%CI 1.12-2.10; p < 0.008), and the level of heterogeneity is low (P = 0.99, I2 = 0%). CONCLUSION: This meta-analysis confirmed the safety of BTX-A in the treatment of facial rejuvenation (CFL, GL, FHL). Although the incidence of adverse reactions was low, there was still a significant difference compared with the placebo control group. LEVEL OF EVIDENCE II: This journal requires that authors assign a level of evidence to each article. For a full description of these Evidence-Based Medicine ratings, please refer to the Table of Contents or the online Instructions to Authors www.springer.com/00266 .

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Botulinum Toxins, Type ARejuvenationSkin AgingNeuromuscular AgentsCosmetic TechniquesHumansRandomized Controlled Trials as TopicTreatment OutcomeFace

Stichwörter der Autor:innen

Adverse reactionsBotulinum toxin AFacial rejuvenationNon-surgical cosmetic treatmentsSafety profile

Substanzen

Botulinum Toxins, Type ANeuromuscular Agents

Autor:innen und Institutionen

  • Burn, Plastic and Wound Repair Surgery, Longyan First Affiliated Hospital of Fujian Medical University, No.105, Jiuyi North Road, Zhongcheng Street, Xinluo District, Longyan, 364000, Fujian Province, China.
  • Burn, Plastic and Wound Repair Surgery, Longyan First Affiliated Hospital of Fujian Medical University, No.105, Jiuyi North Road, Zhongcheng Street, Xinluo District, Longyan, 364000, Fujian Province, China. fjyxdz82@163…

Zitieren

APA

Zhang, W., Wen, Y., Zhong, Y., & Chen, Q. (2025). Meta-Analysis of Adverse Reactions of Botulinum Toxin A in Facial Rejuvenation Treatment. Aesthetic Plastic Surgery. https://doi.org/10.1007/s00266-024-04539-4

Vancouver

Zhang W, Wen Y, Zhong Y, Chen Q. Meta-Analysis of Adverse Reactions of Botulinum Toxin A in Facial Rejuvenation Treatment. Aesthetic Plastic Surgery. 2025. doi:10.1007/s00266-024-04539-4

BibTeX
@article{Zhang2025,
  author = {Zhang, Weiqiang and Wen, Yuqing and Zhong, Yi and Chen, Qingxia},
  title = {Meta-Analysis of Adverse Reactions of Botulinum Toxin A in Facial Rejuvenation Treatment},
  journal = {Aesthetic Plastic Surgery},
  year = {2025},
  doi = {10.1007/s00266-024-04539-4}
}
Kostenlos starten →